Sangamo Biosciences, Inc. (SGMO) Tops Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq ends lower as oil prices surge ahead of earnings, economic data
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Financial Fact:
Loss from operations: -19.21M
Today's EPS Names:
SMXT, NRIX, VFS, More
Financial Fact:
Loss from operations: -19.21M
Today's EPS Names:
SMXT, NRIX, VFS, More
Join SI Premium – FREE
Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q2 EPS of ($0.10), $0.03 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $6.93 million versus the consensus estimate of $4.77 million.
For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.
For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nurix Therapeutics, Inc. (NRIX) Reports Q3 EPS of $4.73
- Wells Fargo names top retailing stock amid shifting market dynamics
- Myomo names new chief commercial officer effective October 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
